RHEUM || Spondyloarthropathies

Traditional risk factors raise cardiovascular risk in PsA

Posted on: 02/04/2015 - 18:28

Psoriatic arthritis is associated with higher rates of self-reported angina pectoris, percutaneous coronary intervention, hypertension, obesity, and s... More »

Field of Interest: Rheumatology

Type: News Item

Acute anterior uveitis? Consider axial spondyloarthritis

Posted on: 06/03/2015 - 16:09

SNOWMASS, COLO. – Ankylosing spondylitis, far and away, is the most common systemic disease in North America associated with uveitis, Dr. James T. R... More »

Field of Interest: Rheumatology

Type: News Item

New psoriasis drugs offer treatment advantages

Posted on: 27/02/2015 - 19:20

MIAMI BEACH – Two of the newest treatments available for psoriasis – apremilast and secukinumab – are true “game-changers,” according to Dr.... More »

Field of Interest: Dermatology

Type: News Item

Data suggest link between tonsillectomy, psoriasis improvement

Posted on: 25/02/2015 - 18:14

MIAMI BEACH – If all else fails in treating psoriasis, a tonsillectomy may do the trick – at least in patients whose psoriasis is associated with ... More »

Field of Interest: Dermatology

Type: News Item

Survey: Psoriasis/psoriatic arthritis undertreated

Posted on: 30/01/2015 - 16:20

ORLANDO – Patients with psoriasis and psoriatic arthritis have a high level of dissatisfaction with current treatment options and have numerous unme... More »

Field of Interest: Rheumatology

Type: News Item

Survey: Psoriasis/psoriatic arthritis undertreated

Posted on: 30/01/2015 - 16:20

ORLANDO – Patients with psoriasis and psoriatic arthritis have a high level of dissatisfaction with current treatment options and have numerous unme... More »

Field of Interest: Dermatology

Type: News Item

Adalimumab effective in nonpsoriatic peripheral spondyloarthritis

Posted on: 09/01/2015 - 15:11

Adalimumab alleviated symptoms and improved physical functions in certain patients with active nonpsoriatic peripheral spondyloarthritis in the first ... More »

Field of Interest: Rheumatology

Type: News Item

Secukinumab tames psoriatic arthritis in FUTURE 2 trial

Posted on: 07/12/2014 - 19:50

BOSTON – Secukinumab improved quality of life and symptoms in patients with psoriatic arthritis, regardless of whether they had received prior anti-tumor-necrosis factor therapy or were concurrently...

Field of Interest: Rheumatology

Type: News Item

Few psoriatic arthritis patients achieve minimal disease activity on methotrexate

Posted on: 05/12/2014 - 16:16

BOSTON – It’s time to test whether methotrexate is really up to snuff as a first-line therapy for psoriatic arthritis, Canadian investigators say. They base that recommendation on findings from a...

Field of Interest: Rheumatology

Type: News Item

TNF-alpha blockers effective in sustaining reduced PsA activity

Posted on: 05/12/2014 - 16:02

A state of minimal disease activity in patients with psoriatic arthritis is sustainable over several years by using treatments with tumor necrosis factor–alpha blockers, according to findings from a...

Field of Interest: Rheumatology

Type: News Item

Newsletters

Stay informed on our latest news!

You are here

Newsletters

Latest Newsletters